HCPCS Level II code G0141 represents an automated screening cytopathology smear of the cervix or vagina that includes manual rescreening and requires physician interpretation. This code captures a hybrid workflow combining automated specimen review with human oversight, an approach increasingly used to improve screening throughput and maintain diagnostic accuracy. Nationally, G0141 is relevant for laboratories, pathology services, and clinicians involved in cervical cancer screening programs.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical role, typical sites of service, and the types of benchmarks and policy considerations that commonly apply to laboratory cytology services. The publication summarizes coding context, common modifier usage (provided separately), and how G0141 fits alongside related cytopathology services.

The report highlights performance and billing benchmarks, payer coverage considerations, and any recent policy or coding guidance affecting automated cytology screening with manual rescreen. It provides clinical context for when automated-plus-manual screening workflows are used and what operational stakeholders should note about documentation and physician interpretation requirements. Data not available in the input are identified as such in relevant sections.